首页 正文

[Treatment options and limitations in the management of myelofibrosis]

{{output}}
Primary myelofibrosis has the worst outcome among classical chronic myeloproliferative neoplasms. The past decade has brought numerous discoveries elucidating the role of proliferative mutations in disease pathogenesis. Mutations of the genes JAK2, MPL and CAL... ...